Two vs three cycles of neoadjuvant sintilimab plus chemotherapy for resectable non-small-cell lung cancer: neoSCORE trial

• Miner Shao,
• Jie Yao,
• Yunke Wang,
• Lufeng Zhao,
• Baizhou Li,
• Lili Li,
• Zuqun Wu,
• Zexin Chen,
• Junqiang Fan,
• Fuming Qiu

Affiliations

Miner Shao

Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine

Jie Yao

Department of Thoracic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine

Yunke Wang

Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine

Lufeng Zhao

Department of Thoracic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine

Baizhou Li

Department of Pathology, The Second Affiliated Hospital, Zhejiang University School of Medicine

Lili Li

Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine

Zuqun Wu

Department of Respiratory Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine

Zexin Chen

Department of Biostatistics, The Second Affiliated Hospital, Zhejiang University School of Medicine

Junqiang Fan

Department of Thoracic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine

Fuming Qiu

Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine